postpartum depression

Postpartum depression (PPD) is a serious public health problem affecting 10% to 15% of women during the first year after delivery with negative consequences for both mother and infant. There is a need for evidence-based interventions to treat this disorder. Thus, the purpose of this study was to systematically review the literature regarding group treatment for PPD to determine the current state of knowledge regarding the efficacy of this treatment modality for reducing depressive symptoms in postpartum women.

Maternal postpartum depression (PPD) and mother-infant relationship dysfunction have reciprocal effects on each other and thus an integrated approach that addresses both problems simultaneously may lead to improved outcomes. This study aimed to determine the feasibility, acceptability, and preliminary efficacy of a new intervention, Perinatal Dyadic Psychotherapy (PDP), for the early treatment of maternal PPD.

The purpose of this study was to pilot test Perinatal Dyadic Psychotherapy, a novel dual-focused mother-infant intervention to prevent/decrease maternal postpartum depression and improve aspects of mother-infant relationships related to child development outcomes in mother-infants dyads in which the mother was experiencing elevated postpartum depression symptoms (sub-threshold or meeting diagnostic criteria for MDD).